Skip to main content

Table 2 Demographic characteristics for the non-demented participants

From: Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive function

Characteristics Group A Group B Group C P
N 84 85 69  
Age (Mean ± SD, year) 74.52 ± 6.65 73.92 ± 6.18 77.30 ± 6.60 0.0038
Sex (Female, %) 39 (46.4) 30 (35.3) 23 (33.3) 0.1872
Education (Mean ± SD, year) 15.73 ± 2.94 15.67 ± 3.13 16.08 ± 2.71 0.6551
APOE ε4 carrier status (Yes, %) 33 (39.3) 33 (38.8) 35 (50.7) 0.5560
WMHV (Mean ± SD, cm3) 1.03 ± 3.49 0.52 ± 0.92 0.87 ± 1.98 0.076
CSF HGF (Mean ± SD, ng/ml) 0.25 ± 0.09 0.44 ± 0.04 0.62 ± 0.07 < 0.0001
  1. All participants were grouped by tertiles of CSF HGF at baseline. Group A lowest tertile; Group B middle tertile; Group C highest tertile. ANOVA, non-parametric Kruskal-Wallis H test, and Chi-squared test were used to compare the baseline demographic and clinical characteristics. Abbreviations: WMHV white matter hyperintensities volume; CSF cerebrospinal fluid; HGF Hepatocyte Growth Factor